Organon (OGN) P/B (2021 - 2026)
Organon (OGN) P/B from May 14, 2021 to Jul 21, 2026. The TTM Organon (OGN) P/B is 3.93. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/B
Annual P/B change of Organon (OGN)
| Year | P/B | Change |
|---|---|---|
| 2026 | 3.93 | +58.32% |
| 2025 | 2.48 | -69.54% |
| 2024 | 8.15 | -230.22% |
| 2023 | -6.26 | -6.10% |
| 2022 | -6.66 | +30.13% |
| 2021 | -5.12 | N/A |
Comparison Organon (OGN) P/B with competitors
Organon (OGN) P/B is 3.93.
| Ticker | Name | P/B | Upside |
|---|---|---|---|
| AMRN | Amarin Corp | 0.68 | -82.59% |
| GRFS | Grifols SA | 0.79 | -79.90% |
| SNY | Sanofi | 1.27 | -67.68% |
| BIIB | Biogen Inc | 1.52 | -61.34% |
| PFE | Pfizer Inc | 1.55 | -60.61% |
| MIRA | Mira Pharmaceuticals Inc | 4.09 | +4.11% |
| GSK | GSK Plc | 4.37 | +11.26% |
| BMY | Bristol-Myers Squibb Company | 6.04 | +53.71% |
| AZN | Astrazeneca plc | 6.20 | +57.78% |
| MRK | Merck & Co Inc | 6.68 | +69.99% |
| GILD | Gilead Sciences Inc | 6.94 | +76.61% |
| NVO | Novo Nordisk | 7.07 | +79.92% |
| NVS | Novartis AG | 7.60 | +93.41% |
| JNJ | Johnson & Johnson | 7.64 | +94.42% |
| NSRX | Nasus Pharma Ltd | 12.90 | +228.28% |
| MDCX | MDCorp | 15.34 | +290.38% |
| AMGN | AMGEN Inc | 21.17 | +438.74% |
| SCLX | Scilex Holding Company | 28.85 | +634.18% |
| LLY | Lilly(Eli) & Company | 32.94 | +738.26% |
| ABBV | Abbvie Inc | 50.46 | +1184.11% |